Cargando…
miR-19a acts as an oncogenic microRNA and is up-regulated in bladder cancer
BACKGROUND: The application of microRNAs (miRNAs) as potential biomarkers and therapy targets has been widely investigated in many kinds of cancers. The discovery of tumor associated miRNAs in serum of patients supported the use of plasma/serum miRNAs as noninvasive means of cancer detection. Howeve...
Autores principales: | Feng, Yougang, Liu, Jun, Kang, Yongming, He, Yue, Liang, Bo, Yang, Ping, Yu, Zhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237814/ https://www.ncbi.nlm.nih.gov/pubmed/25107371 http://dx.doi.org/10.1186/s13046-014-0067-8 |
Ejemplares similares
-
microRNA-99a acts as a tumor suppressor and is down-regulated in bladder cancer
por: Feng, Yougang, et al.
Publicado: (2014) -
Epigenetic control of an oncogenic microRNA, miR-155, by BRCA1
por: Chang, Suhwan, et al.
Publicado: (2012) -
The Oncogenic MicroRNA miR-21 Promotes Regulated Necrosis in Mice
por: Ma, Xiaodong, et al.
Publicado: (2015) -
Oncogenic MicroRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum
por: Sochor, Marek, et al.
Publicado: (2014) -
The Breast Cancer Oncogene EMSY Represses Transcription of Antimetastatic microRNA miR-31
por: Viré, Emmanuelle, et al.
Publicado: (2014)